Subscription banner for an ophthalmic newsletter
VSY Biotechnology Announces Winners of the Ophthalmology Star Awards 2024 (OSA) at ESCRS Congress

VSY Biotechnology Announces Winners of the Ophthalmology Star Awards 2024 (OSA) at ESCRS Congress

September 09, 2024

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, proudly announced the winners of the prestigious Ophthalmology Star Awards 2024 (OSA) during the Satellite Symposium at the ESCRS 2024 Congress in Barcelona. The annual Ophthalmology Star Awards ceremony honors remarkable contributions to ophthalmology, celebrating individuals whose groundbreaking research and clinical advancements have significantly enhanced our understanding and treatment of eye diseases.

This year, VSY Biotechnology is excited to acknowledge the following distinguished researchers for their exceptional clinical studies:

First Place Winner: Suphi Taneri, Germany Study Title: Decision-Making in Corneal Refractive Surgery

Second Place Winner: Liliana Werner, USA Study Title: Rotational Stability of a New Hydrophobic Acrylic Intraocular Lens Platform

Third Place Winner: Paolo Fogagnolo, Italy Study Title: Sural Nerve Vertical Cross-Face Graft for Lacrimal Gland Neurotization to Improve Tear Secretion in Neurogenic Dry Eye

All prizes were personally presented to the winners by Dr. Florian Kretz, recognizing their outstanding contributions and commitment to advancing the field of ophthalmology.

These award recipients have exhibited extraordinary dedication, innovation, and expertise in their respective areas of research. Their contributions are set to redefine how ophthalmologists approach the diagnosis and treatment of eye conditions, ultimately enhancing patient care worldwide.

As a company committed to pushing the boundaries of ophthalmic science and technology, VSY Biotechnology is proud to support and honor these exceptional researchers. We look forward to the transformative impact their work will have on the field of ophthalmology and the lives of patients globally.